All Articles

Browse the full archive, newest first.

Travel

Briefing: 2026 Dodge Charger Sixpack R/T 4-Door Aims For Broad Appeal, And Kind Of Succeeds

Strategic angle: This car may help Dodge's sales woes, but it raises questions about value and performance.

editorial-staff Mar 9

Tech

Briefing: AI Agenda: Anthropic Has a Strong Legal Case Against Trump’s DoD

Strategic angle: The Information reports on Anthropic's legal stance regarding the Department of Defense.

editorial-staff Mar 9

Politics

Briefing: Justice Department Advocates for New Interpretation of Birthright Citizenship

Strategic angle: In a pivotal case, the Justice Department calls for a modern approach to an age-old legal principle regarding citizenship at birth.

editorial-staff Mar 9

Tech

Briefing: Microsoft debuts Copilot Cowork built on Anthropic's tech and E7 product suite

Strategic angle: Microsoft introduces a new AI-driven collaboration tool leveraging Anthropic's technology.

editorial-staff Mar 9

Tech

Briefing: The Usability Imperative for Securing Digital Asset Devices

Strategic angle: Exploring the balance between usability and security in digital asset technology.

editorial-staff Mar 9

Money

Briefing: Recession odds jump on Kalshi after oil tops $100

Strategic angle: Prediction market bettors are increasingly expecting the U.S. economy to enter a recession.

editorial-staff Mar 9

Politics

Briefing: Europe is ‘unknown variable’ in US-China rivalry, Barrot says, urging EU to overcome ‘deep doubt'

Strategic angle: The French foreign minister emphasizes the urgency for Europe to address its uncertainties in the face of US-China tensions.

editorial-staff Mar 9

Life

Briefing: Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy sales

Strategic angle: Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter dispute around Hims’ sale of compounded versions of Novo’s blockbuster obesity drug.

editorial-staff Mar 9

Life

Briefing: Fresh turmoil at the FDA with Prasad’s exit

Strategic angle: Prasad out again, generic Ozempic on its way, and more health news from Morning Rounds

editorial-staff Mar 9

Life

Briefing: Lack of FDA Advisory Committees Raises Concerns

Strategic angle: Growing worries about the FDA's diminishing use of advisory committees for public discourse.

editorial-staff Mar 9